Related Experiment Video

Updated: Jul 13, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts

S C Metcalf1, D H Dockrell

  • 1Communicable Diseases Directorate, E Floor, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.

The Journal of Infection
|August 19, 2007
PubMed

Insights

New antifungals and diagnostic tools offer hope for invasive fungal infections, particularly invasive aspergillosis. Clinical trials guide optimal use of voriconazole, posaconazole, and echinocandins, improving outcomes for immunocompromised patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Invasive fungal infections (IFIs) pose significant risks, especially in immunocompromised individuals.
  • Treatment response rates for invasive aspergillosis and invasive mould infections have historically been low.
  • Advances in early diagnosis and potent, less toxic antifungal agents are improving IFI management.

Purpose of the Study:

  • To review recent advancements in the diagnosis and treatment of invasive fungal infections.
  • To highlight the clinical utility of newer antifungal agents and formulations.
  • To identify remaining therapeutic uncertainties and future research directions.

Main Methods:

  • Review of recent clinical trials and therapeutic guidelines for invasive fungal infections.
  • Analysis of the efficacy and safety profiles of key antifungal agents, including lipid formulations of amphotericin B, extended-spectrum azoles, and echinocandins.
  • Evaluation of specific agents like voriconazole, posaconazole, and caspofungin in various clinical scenarios.

Main Results:

  • Voriconazole demonstrated superior efficacy compared to amphotericin B for invasive aspergillosis.
  • Posaconazole showed efficacy in prophylaxis and salvage therapy for IFIs in high-risk patients.
  • Echinocandins (e.g., caspofungin) are effective and well-tolerated for invasive candidiasis and salvage therapy.

Conclusions:

  • Newer antifungal therapies offer improved outcomes for IFIs.
  • Voriconazole, posaconazole, and echinocandins represent significant therapeutic advances.
  • Further research is needed, particularly on combination therapy, to address remaining challenges in IFI treatment.

More Related Videos

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense06:53

An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense

Published on: April 17, 2026

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...